$AMGN Headlines FDA panel recommends approval
Post# of 102254
Posted On: 01/23/2015 11:54:23 AM
$AMGN Headlines
FDA panel recommends approval for first generic biotech drug 4:51 p.m. Jan. 7, 2015 - Wallace Witkowski
Novartis wins FDA staff Ok for Neupogen generic 12:46 p.m. Jan. 5, 2015 - Marta Falconi
Amgen and Kite Pharma in cancer immunotherapy pact 10:00 a.m. Jan. 5, 2015 - Tess Stynes
Cal-Maine Foods shares fall on earnings miss 4:41 p.m. Dec. 23, 2014 - Barbara Kollmeyer
Amgen boosts first-quarter dividend 30% to 79 cents a share 5:46 p.m. Dec. 17, 2014 - Tom Bemis
Amgen ends trials of stomach-cancer therapy 9:57 a.m. Nov. 24, 2014 - Tess Stynes
Amgen's stock drops after trial misses secondary endpoint 9:20 a.m. Nov. 4, 2014 - Tomi Kilgore
Amgen's stock drops 2% in premarket trade 9:07 a.m. Nov. 4, 2014 - Tomi Kilgore
Amgen study on cancer treatment misses secondary endpoint 9:06 a.m. Nov. 4, 2014 - Tomi Kilgore
Facebook, Gilead shares fall after hours 6:14 p.m. Oct. 28, 2014 - Sue Chang
Amgen, under investor pressure, outlines strategy 10:05 a.m. Oct. 28, 2014 - MarketWatch.com
Amgen's stock rises after company outlines capital allocation plans 9:07 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen's stock climbs 3.2% in premarket trade after capital allocation plans 8:55 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen sees 2015 revenue $20.8 bln-$21.3 bln vs. FactSet consensus $20.33 bln 8:54 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen sees 2015 adj. EPS $9.05-$9.40 vs. FactSet consensus $9.08 8:53 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen plans to payout 60% of adj. earnings to shareholders through 2018 8:52 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen plans to raise dividend 30% starting in Q1 2015 8:52 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen resumes share buybacks, with plans for $2 bln in repurchases through 2015 8:51 a.m. Oct. 28, 2014 - Tomi Kilgore
‘Dumb money’ unloads bullish oil bets as prices pose threat to stocks 8:35 a.m. Oct. 28, 2014 - Shawn Langlois
4 more ‘Amazon’ stocks you may want to avoid 8:43 p.m. Oct. 27, 2014 - Philip van Doorn
What Lessons Has Express Scripts Taught Us? The Future For The Pharmaceutical Industry 7:30 a.m. Today - Seeking Alpha
New Guru Jana Partners' Newest Stock Buys 8:05 p.m. Jan. 22, 2015 - GuruFocus.com
UCB's New Epilepsy Drug Under Review in the U.S., EU - Analyst Blog 7:00 p.m. Jan. 22, 2015 - Zacks.com
Curis Up on Immuno-Oncology Agreement with Aurigene - Analyst Blog 6:35 p.m. Jan. 22, 2015 - Zacks.com
2014 Portfolio Review: Year One Of My DGI Journey, Part I 6:29 p.m. Jan. 22, 2015 - Seeking Alpha
BioMarin to Raise Funds to Finance Prosensa Acquisition - Analyst Blog 6:00 p.m. Jan. 22, 2015 - Zacks.com
Novartis' Psoriasis Drug Cosentyx Gets FDA Approval - Analyst Blog 5:40 p.m. Jan. 22, 2015 - Zacks.com
Keryx to Raise $110 Million Through Issuance of Shares - Analyst Blog 4:10 p.m. Jan. 22, 2015 - Zacks.com
Bristol-Myers Makes Leadership Changes, Names New CEO - Analyst Blog 6:13 p.m. Jan. 21, 2015 - Zacks.com
Hospira's Plum 36O Infusion System Gets FDA Clearance - Analyst Blog 6:08 p.m. Jan. 21, 2015 - Zacks.com
Alnylam to Raise $450 Million Through Issuance of Shares - Analyst Blog 5:00 p.m. Jan. 21, 2015 - Zacks.com
Affymetrix Hits 52-Week High on Strong Top-Line Growth - Analyst Blog 12:50 p.m. Jan. 21, 2015 - Zacks.com
Biotech Stock Roundup: EU Approvals for AbbVie & Celgene Drugs, CytRx Partial Clinical Hold Lifted - Analyst Blog 11:02 a.m. Jan. 21, 2015 - Zacks.com
Novartis' Cosentyx Approved in Europe for Plaque Psoriasis - Analyst Blog 6:03 p.m. Jan. 20, 2015 - Zacks.com
Supernus Downgraded as Lead Drugs Face Patent Challenges - Analyst Blog 5:00 p.m. Jan. 20, 2015 - Zacks.com
Sanofi and Boehringer Ingelheim Ink Strategic Deal - Analyst Blog 3:30 p.m. Jan. 20, 2015 - Zacks.com
AZN, ABT And AMGN, 3 Drugs Stocks Pushing The Industry Lower 12:20 p.m. Jan. 20, 2015 - TheStreet.com
J&J Beats on Q4 Earnings, Revenues Hit by Currency - Analyst Blog 11:55 a.m. Jan. 20, 2015 - Zacks.com
Find Your Dividend Yield Sweet Spot 10:11 a.m. Jan. 20, 2015 - Seeking Alpha
AbbVie Gains EU Approval for Hepatitis C Virus Treatment - Analyst Blog 6:35 p.m. Jan. 19, 2015 - Zacks.com
Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 4:01 p.m. Jan. 22, 2015 - PR Newswire - PRF
Technology Industry Leaders to Join Gala Global, Inc. Board of Directors 8:01 a.m. Jan. 21, 2015 - GlobeNewswire
Global Cancer Biomarkers Market 2015-2019 1:24 p.m. Jan. 20, 2015 - PR Newswire - PRF
Amgen Presents New Data Supporting First-Line Use Of Vectibix® (Panitumumab) In Combination With FOLFOX In Patients With Wild-Type RAS Metastatic Colorectal Cancer 4:01 p.m. Jan. 15, 2015 - PR Newswire - PRF
Global Ankylosing Spondylitis Market 2015-2019 4:16 p.m. Jan. 14, 2015 - PR Newswire - PRF
NantWorks Announces Launch of an Immuno-Oncology Company, NantCell, and Licensing Agreement with Amgen for an Oncology Antibody 8:01 a.m. Jan. 14, 2015 - BusinessWire - BZX
3D Bioprinting Pioneers RBCC and n3D Biosciences Network With Top Biotechnology Investors This Week at Biotech Showcase 2015 in San Francisco 5:00 a.m. Jan. 13, 2015 - BusinessWire - BZX
Amgen and MD Anderson Announce Agreement to Develop BiTE® Therapies for Myelodysplastic Syndrome 4:01 p.m. Jan. 12, 2015 - PR Newswire - PRF
Hospira Submits New Biologics License Application to U.S. FDA for Proposed Epoetin Alfa Biosimilar 9:00 a.m. Jan. 12, 2015 - PR Newswire - PRF
WuXi PharmaTech Acquires NextCODE Health to Create Global Leader in Genomic Medicine 8:00 a.m. Jan. 9, 2015 - PR Newswire - PRF
Amgen To Present At The 33rd Annual J.P. Morgan Healthcare Conference 4:15 p.m. Jan. 8, 2015 - PR Newswire - PRF
Surface Oncology Announces $35 Million Series A Financing to Advance Next-Generation Cancer Immunotherapies 7:30 a.m. Jan. 8, 2015 - BusinessWire - BZX
Global Psoriasis Therapeutics Market 2015-2019 2:12 p.m. Jan. 7, 2015 - PR Newswire - PRF
Amgen and Kite Pharma Announce Strategic Cancer Immunotherapy Collaboration to Advance the Application of Novel Chimeric Antigen Receptor (CAR) T Cell Therapies 9:00 a.m. Jan. 5, 2015 - PR Newswire - PRF
Technical Report on Biotech Stocks -- MannKind, Amgen, Celldex Therapeutics, Juno Therapeutics, and Ironwood Pharma 8:35 a.m. Dec. 31, 2014 - PR Newswire - PRF
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Amgen Joins With LabCentral To Support Life-Sciences And Biotech Startups In Cambridge, Massachusetts 9:15 a.m. Dec. 22, 2014 - PR Newswire - PRF
Myriad Genetics Names Bernard Tobin as President of Crescendo Bioscience 7:00 a.m. Dec. 22, 2014 - GlobeNewswire
Amgen Announces 30 Percent Increase In 2015 First Quarter Dividend 5:45 p.m. Dec. 17, 2014 - PR Newswire - PRF
Apotex Announces FDA Has Accepted For Filing its Biosimilar Application for Pegfilgrastim 10:23 a.m. Dec. 17, 2014 - PR Newswire - PRF
FDA panel recommends approval for first generic biotech drug 4:51 p.m. Jan. 7, 2015 - Wallace Witkowski
Novartis wins FDA staff Ok for Neupogen generic 12:46 p.m. Jan. 5, 2015 - Marta Falconi
Amgen and Kite Pharma in cancer immunotherapy pact 10:00 a.m. Jan. 5, 2015 - Tess Stynes
Cal-Maine Foods shares fall on earnings miss 4:41 p.m. Dec. 23, 2014 - Barbara Kollmeyer
Amgen boosts first-quarter dividend 30% to 79 cents a share 5:46 p.m. Dec. 17, 2014 - Tom Bemis
Amgen ends trials of stomach-cancer therapy 9:57 a.m. Nov. 24, 2014 - Tess Stynes
Amgen's stock drops after trial misses secondary endpoint 9:20 a.m. Nov. 4, 2014 - Tomi Kilgore
Amgen's stock drops 2% in premarket trade 9:07 a.m. Nov. 4, 2014 - Tomi Kilgore
Amgen study on cancer treatment misses secondary endpoint 9:06 a.m. Nov. 4, 2014 - Tomi Kilgore
Facebook, Gilead shares fall after hours 6:14 p.m. Oct. 28, 2014 - Sue Chang
Amgen, under investor pressure, outlines strategy 10:05 a.m. Oct. 28, 2014 - MarketWatch.com
Amgen's stock rises after company outlines capital allocation plans 9:07 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen's stock climbs 3.2% in premarket trade after capital allocation plans 8:55 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen sees 2015 revenue $20.8 bln-$21.3 bln vs. FactSet consensus $20.33 bln 8:54 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen sees 2015 adj. EPS $9.05-$9.40 vs. FactSet consensus $9.08 8:53 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen plans to payout 60% of adj. earnings to shareholders through 2018 8:52 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen plans to raise dividend 30% starting in Q1 2015 8:52 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen resumes share buybacks, with plans for $2 bln in repurchases through 2015 8:51 a.m. Oct. 28, 2014 - Tomi Kilgore
‘Dumb money’ unloads bullish oil bets as prices pose threat to stocks 8:35 a.m. Oct. 28, 2014 - Shawn Langlois
4 more ‘Amazon’ stocks you may want to avoid 8:43 p.m. Oct. 27, 2014 - Philip van Doorn
What Lessons Has Express Scripts Taught Us? The Future For The Pharmaceutical Industry 7:30 a.m. Today - Seeking Alpha
New Guru Jana Partners' Newest Stock Buys 8:05 p.m. Jan. 22, 2015 - GuruFocus.com
UCB's New Epilepsy Drug Under Review in the U.S., EU - Analyst Blog 7:00 p.m. Jan. 22, 2015 - Zacks.com
Curis Up on Immuno-Oncology Agreement with Aurigene - Analyst Blog 6:35 p.m. Jan. 22, 2015 - Zacks.com
2014 Portfolio Review: Year One Of My DGI Journey, Part I 6:29 p.m. Jan. 22, 2015 - Seeking Alpha
BioMarin to Raise Funds to Finance Prosensa Acquisition - Analyst Blog 6:00 p.m. Jan. 22, 2015 - Zacks.com
Novartis' Psoriasis Drug Cosentyx Gets FDA Approval - Analyst Blog 5:40 p.m. Jan. 22, 2015 - Zacks.com
Keryx to Raise $110 Million Through Issuance of Shares - Analyst Blog 4:10 p.m. Jan. 22, 2015 - Zacks.com
Bristol-Myers Makes Leadership Changes, Names New CEO - Analyst Blog 6:13 p.m. Jan. 21, 2015 - Zacks.com
Hospira's Plum 36O Infusion System Gets FDA Clearance - Analyst Blog 6:08 p.m. Jan. 21, 2015 - Zacks.com
Alnylam to Raise $450 Million Through Issuance of Shares - Analyst Blog 5:00 p.m. Jan. 21, 2015 - Zacks.com
Affymetrix Hits 52-Week High on Strong Top-Line Growth - Analyst Blog 12:50 p.m. Jan. 21, 2015 - Zacks.com
Biotech Stock Roundup: EU Approvals for AbbVie & Celgene Drugs, CytRx Partial Clinical Hold Lifted - Analyst Blog 11:02 a.m. Jan. 21, 2015 - Zacks.com
Novartis' Cosentyx Approved in Europe for Plaque Psoriasis - Analyst Blog 6:03 p.m. Jan. 20, 2015 - Zacks.com
Supernus Downgraded as Lead Drugs Face Patent Challenges - Analyst Blog 5:00 p.m. Jan. 20, 2015 - Zacks.com
Sanofi and Boehringer Ingelheim Ink Strategic Deal - Analyst Blog 3:30 p.m. Jan. 20, 2015 - Zacks.com
AZN, ABT And AMGN, 3 Drugs Stocks Pushing The Industry Lower 12:20 p.m. Jan. 20, 2015 - TheStreet.com
J&J Beats on Q4 Earnings, Revenues Hit by Currency - Analyst Blog 11:55 a.m. Jan. 20, 2015 - Zacks.com
Find Your Dividend Yield Sweet Spot 10:11 a.m. Jan. 20, 2015 - Seeking Alpha
AbbVie Gains EU Approval for Hepatitis C Virus Treatment - Analyst Blog 6:35 p.m. Jan. 19, 2015 - Zacks.com
Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 4:01 p.m. Jan. 22, 2015 - PR Newswire - PRF
Technology Industry Leaders to Join Gala Global, Inc. Board of Directors 8:01 a.m. Jan. 21, 2015 - GlobeNewswire
Global Cancer Biomarkers Market 2015-2019 1:24 p.m. Jan. 20, 2015 - PR Newswire - PRF
Amgen Presents New Data Supporting First-Line Use Of Vectibix® (Panitumumab) In Combination With FOLFOX In Patients With Wild-Type RAS Metastatic Colorectal Cancer 4:01 p.m. Jan. 15, 2015 - PR Newswire - PRF
Global Ankylosing Spondylitis Market 2015-2019 4:16 p.m. Jan. 14, 2015 - PR Newswire - PRF
NantWorks Announces Launch of an Immuno-Oncology Company, NantCell, and Licensing Agreement with Amgen for an Oncology Antibody 8:01 a.m. Jan. 14, 2015 - BusinessWire - BZX
3D Bioprinting Pioneers RBCC and n3D Biosciences Network With Top Biotechnology Investors This Week at Biotech Showcase 2015 in San Francisco 5:00 a.m. Jan. 13, 2015 - BusinessWire - BZX
Amgen and MD Anderson Announce Agreement to Develop BiTE® Therapies for Myelodysplastic Syndrome 4:01 p.m. Jan. 12, 2015 - PR Newswire - PRF
Hospira Submits New Biologics License Application to U.S. FDA for Proposed Epoetin Alfa Biosimilar 9:00 a.m. Jan. 12, 2015 - PR Newswire - PRF
WuXi PharmaTech Acquires NextCODE Health to Create Global Leader in Genomic Medicine 8:00 a.m. Jan. 9, 2015 - PR Newswire - PRF
Amgen To Present At The 33rd Annual J.P. Morgan Healthcare Conference 4:15 p.m. Jan. 8, 2015 - PR Newswire - PRF
Surface Oncology Announces $35 Million Series A Financing to Advance Next-Generation Cancer Immunotherapies 7:30 a.m. Jan. 8, 2015 - BusinessWire - BZX
Global Psoriasis Therapeutics Market 2015-2019 2:12 p.m. Jan. 7, 2015 - PR Newswire - PRF
Amgen and Kite Pharma Announce Strategic Cancer Immunotherapy Collaboration to Advance the Application of Novel Chimeric Antigen Receptor (CAR) T Cell Therapies 9:00 a.m. Jan. 5, 2015 - PR Newswire - PRF
Technical Report on Biotech Stocks -- MannKind, Amgen, Celldex Therapeutics, Juno Therapeutics, and Ironwood Pharma 8:35 a.m. Dec. 31, 2014 - PR Newswire - PRF
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Amgen Joins With LabCentral To Support Life-Sciences And Biotech Startups In Cambridge, Massachusetts 9:15 a.m. Dec. 22, 2014 - PR Newswire - PRF
Myriad Genetics Names Bernard Tobin as President of Crescendo Bioscience 7:00 a.m. Dec. 22, 2014 - GlobeNewswire
Amgen Announces 30 Percent Increase In 2015 First Quarter Dividend 5:45 p.m. Dec. 17, 2014 - PR Newswire - PRF
Apotex Announces FDA Has Accepted For Filing its Biosimilar Application for Pegfilgrastim 10:23 a.m. Dec. 17, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼